Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The aim of this review is to explore the dysregulation of adrenocortical secretions as a major contributor in the development of obesity and insulin resistance. Disturbance of adipose tissue physiology is one of the primary events in the development of pathologies associated with the metabolic syndrome, such as obesity and type 2 diabetes. Several studies indicate that alterations in metabolism of glucocorticoids (GC) and androgens, as well as aldosterone in excess, are involved in the emergence of metabolic syndrome. Cross talk among adipose tissue, the hypothalamo-pituitary complex, and adrenal gland activity plays a major role in the control of food intake, glucose metabolism, lipid storage, and energy balance. Perturbation of this cross talk induces alterations in the regulatory mechanisms of adrenocortical steroid synthesis, secretion, degradation, and/or recycling, at the level of the zonae glomerulosa (aldosterone), fasciculata (GC and GC metabolites), and reticularis (androgens and androgen precursors DHEA and DHEAS). As a whole, these adrenocortical perturbations contribute to the development of metabolic syndrome at both the paracrine and systemic level by favoring the physiological dysregulation of organs responsive to aldosterone, GC, and/or androgens, including adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“Indeed, chronically elevated GC levels redistribute fat from subcutaneous depots to visceral adipose tissue (48), abdominal obesity being a critical feature of metabolic syndrome (55).”
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“At the cellular level, GC may reduce insulin signaling via stimulation of oxygen species production and oxidative stress (88).”
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 13×
“The types 1 and 2 steroid-5 -reductases (SRD5A1 and SRD5A2) are also involved in the conversion of adrenal precursors and testosterone into 5 -dihydrotestosterone (DHT), the most potent natural androgen, and may thus be involved in increased production of androgens observed in AJP-Endocrinol Metab • VOL 293 • DECEMBER…”
InfluentialArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Chronic stress and obesity: a new view of “comfort food”
Dallman, M. F., Pecoraro, N., Akana, S. F., la Fleur, S. E., Gomez, F., Houshyar, H., Bell, M. E., Bhatnagar, S., Laugero, K. D., & Manalo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934666100 · Cited by 1,369 · cited 1×
“Several reports indicate that chronic GC excess is also able to increase food intake (“stress eating”) (23, 48, 49).”
Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes
Spiegel, K., Knutson, K., Leproult, R., Tasali, E., & Cauter, E. V. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00660.2005 · Cited by 1,175
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978 · cited 1×
“They are activated by oxysterols (oxygenated derivatives of cholesterol), and are now recognized as integrators of metabolic and inflammation pathways (204) as well as regulators of adrenal steroidogenesis and HPA axis feedback (134).”
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 1×
“In addition, the endocannabinoid system, which is associated with the control of food intake, energy balance, stress and peripheral glucose and lipid metabolism, has recently been linked to obesity and the metabolic syndrome (29, 66, 121, 139).”
Studies on the Physiological Functions of the Melanocortin System
Cone, R. D. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0034 · Cited by 615 · cited 1×
“ACTH is produced from the larger precursor proopiomelanocortin (POMC), which is also the precursor of the melanocortins -, - and -MSH (melanocyte-stimulating hormones) (43).”
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600 · cited 2×
“The adrenal cortex synthesizes and secretes steroids, while the medulla produces catecholamines and several neuropeptides (53, 64).”
Kupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner, W. J., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1326 · Cited by 561 · cited 1×
“Interestingly, androgens are associated with metabolic syndrome in a dichotomous fashion depending on the sex, since it is rather low testosterone levels that strongly correlate with different components of the metabolic syndrome in men (102, 140, 176).”
Hunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
Dagenais, G. R., Pogue, J., Fox, K., Simoons, M. L., & Yusuf, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69201-5 · Cited by 514 · cited 1×
“AT1R blockade may even prevent IR and development of type 2 diabetes by stimulating adipocyte recruitment and differentiation, thus protecting other organs from lipid deposition (47, 165) (Fig.”
Morton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · cited 23×
“Indeed, PPAR pharmacological agonists, such as thiazolidinediones (TZDs) are known to inhibit growth and androgen production in the human ANG II-responsive adrenocortical cancer cell line H295R (68, 96).”
InfluentialObesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Impact of Sleep and Sleep Loss on Neuroendocrine and Metabolic Function
van Cauter, E., Holmbäck, U., Knutson, K., Leproult, R., Miller, A., Nedeltcheva, A., Pannain, S., Penev, P., Tasali, E., & Spiegel, K. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097543 · Cited by 353
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337 · cited 1×
“Since the inhibition of adipogenesis obtained by siRNA-induced MR downregulation is not mimicked by specific GR inactivation, MR may thus act as a proadipogenic transcription factor mediating the effects of both aldosterone and GC (37).”
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 14×
“The types 1 and 2 steroid-5 -reductases (SRD5A1 and SRD5A2) are also involved in the conversion of adrenal precursors and testosterone into 5 -dihydrotestosterone (DHT), the most potent natural androgen, and may thus be involved in increased production of androgens observed in AJP-Endocrinol Metab • VOL 293 • DECEMBER…”
InfluentialThe renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267 · cited 25×
“Activation of AT2R mediates the ANG II-induced increase in expression of adiponectin, an insulin-sensitizing hormone secreted by adipose tissue (41), whereas AT1R mediates a decrease in plasma adiponectin levels (155) (Fig.”
InfluentialVillareal, D. T., & Holloszy, J. O. (2004) · JAMA · doi:10.1001/jama.292.18.2243 · Cited by 241
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
de Paula, R. B., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000105624.68174.00 · Cited by 207 · cited 1×
“The fact that blockade of aldosterone action by aldosterone antagonists significantly attenuates the rise in arterial pressure in diet-induced obesity in dogs supports the importance of this hormone in the development of obesity-related hypertension (51).”
Pralong, F. P., Roduit, R., Waeber, G., Castillo, E., Mosimann, F., Thorens, B., & Gaillard, R. C. (1998) · Endocrinology · doi:10.1210/endo.139.10.6254 · Cited by 202 · cited 1×
“Leptin from the adjacent or intra-adrenal adipose tissue (65) also acts directly at the adrenal gland level by inhibiting its growth and GC secretion (150, 193).”
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280108e6f · Cited by 196 · cited 1×
“Aldosterone excess is also associated with glucometabolic alterations and IR in the cardiovascular system (76, 77).”
5 α-reductase activity in polycystic ovary syndrome
Stewart, P. M., Edwards, C. R. W., Shackleton, C. H. L., & Beastall, G. H. (1990) · The Lancet · doi:10.1016/0140-6736(90)90664-q · Cited by 189
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176 · cited 1×
“Peroxisome proliferator-activated receptors (PPAR , - , and - ) are members of the nuclear receptor family and play a key role in the regulation of adipocyte differentiation, insulin sensitivity, glucose and lipid metabolism, and inflammation (21, 25, 56).”
The Biodisposition and Metabolism of Anandamide in Mice
Willoughby, K. A., Moore, S. F., Martin, B. R., & Ellis, E. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36812-0 · Cited by 159 · cited 1×
“Among all tissues, the adrenal gland displays the highest accumulation of anandamide, an endogenous CB1 ligand, associated with a low level of anandamide metabolism (198), which suggests that the adrenal gland may be a major target organ for pharmacological CB1 antagonists.”
Fassnacht, M., Schlenz, N., Schneider, S. B., Wudy, S. A., Allolio, B., & Arlt, W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021875 · Cited by 158 · cited 14×
“The types 1 and 2 steroid-5 -reductases (SRD5A1 and SRD5A2) are also involved in the conversion of adrenal precursors and testosterone into 5 -dihydrotestosterone (DHT), the most potent natural androgen, and may thus be involved in increased production of androgens observed in AJP-Endocrinol Metab • VOL 293 • DECEMBER…”
InfluentialTsilchorozidou, T., Honour, J. W., & Conway, G. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030240 · Cited by 155
Armando, I., Carranza, A., Nishimura, Y., Hoe, K.-L., Barontini, M., Terrón, J. A., Falcón-Neri, A., Ito, T., Juorio, A. V., & Saavedra, J. M. (2001) · Endocrinology · doi:10.1210/endo.142.9.8366 · Cited by 148
Direct Regulation of Hypothalamic Corticotropin-Releasing-Hormone Neurons by Angiotensin II
Aguilera, G., Young, W. S., Kiss, A., & Bathia, A. (2008) · Neuroendocrinology · doi:10.1159/000126866 · Cited by 144 · cited 1×
“93), increasing the expression of CRH in the paraventricular nucleus (PVN), in the hypothalamus (2, 10, 92).”
van Harmelen, V, Elizalde, M., Ariapart, P., Bergstedt-Lindqvist, S., Reynisdottir, S., Hoffstedt, J., Lundkvist, I., Bringman, S., & Arner, P. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801217 · Cited by 114
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
Blouin, K., Richard, C., Brochu, G., Hould, F.-S., Lebel, S., Marceau, S., Biron, S., Luu-The, V., & Tchernof, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06365 · Cited by 90 · cited 3×
“Since DHEA is already known to inhibit GC recycling by reducing 11 -HSD1 adipose tissue expression (7, 28), it would be interesting to know whether this LXR-induced inhibition of GC recycling may be related to a concomitant increased DHEA production by the adrenal gland.”
Goossens, G. H., Blaak, E. E., Saris, W. H. M., & van Baak, M. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032053 · Cited by 84
Gambineri, A., Vicennati, V., Genghini, S., Tomassoni, F., Pagotto, U., Pasquali, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2222 · Cited by 75
Blouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V., & Tchernof, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2004 · Cited by 67 · cited 1×
“Androgen inactivation is higher in abdominal adipose tissue in obese compared with lean persons, surprisingly for both men (28) and women (26, 27).”
Fat tissue metabolism and adrenal steroid secretion
Lamounier-Zepter, V., & Ehrhart-Bornstein, M. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0038-3 · Cited by 34 · cited 1×
“Various clinical studies have documented elevated plasma aldosterone levels in obese patients, especially those with visceral obesity (80, 82, 106, 171, 179).”
Cited by
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186
“Functional relationships between adipocytes and the renin-angiotensin-aldosterone system [91] or between adipocytes and adrenocortex/aldosterone [92] do probably deserve more attention.”
BackgroundThe circadian clock in cancer development and therapy
Fu, L., & Kettner, N. M. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396971-2.00009-9 · Cited by 251
Diabetes and sleep: a complex cause-and-effect relationship
Barone, M. T. U., & Menna-Barreto, L. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.07.011 · Cited by 209
Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism
Silverman, J. L., Yang, M., Turner, S. M., Katz, A. M., Bell, D. B., Koenig, J. I., & Crawley, J. N. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.059 · Cited by 146
Pros and cons of screening for occult Cushing syndrome
Tabarin, A., & Perez, P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.51 · Cited by 57
“Systematic screening studies Screening patients with diabetes mellitus Cortisol plays a key part in glucose metabolism and acts on critical target tissues, such as liver, adipose tissue, skeletal muscle and the endocrine pancreas”
Background
Metadata
- Authors
- Roberge, C., Carpentier, A. C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., & Gallo-Payet, N.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2007-12
- Volume
- 293
- Issue
- 6
- Pages
- E1465-E1478
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2099796585
- Cited by
- 89
- References
- 39
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.